BioMarin Pharmaceuticals BMRN Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's shares (basic)?
- BioMarin Pharmaceuticals (BMRN) reported shares (basic) of 192.5M in Q1 2026.
- How has BioMarin Pharmaceuticals's shares (basic) changed year-over-year?
- BioMarin Pharmaceuticals's shares (basic) increased by 0.8% year-over-year, from 191M to 192.5M.
- What is the long-term trend for BioMarin Pharmaceuticals's shares (basic)?
- Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's shares (basic) has grown at a 1.2% compound annual growth rate (CAGR), from 730.7M to 766.7M.
- What does shares (basic) mean?
- The average number of common shares held by investors during the period.
- How do you interpret shares (basic)?
- An increase indicates share issuance, which may dilute existing shareholders, while a decrease indicates share buybacks.
- How does shares (basic) compare across companies?
- Used to normalize earnings across different periods and companies with varying capital structures.